Title | Geography | Industry | ||||
---|---|---|---|---|---|---|
Number of ongoing Clinical Trials (for drugs) involving Nocturia by Phase | Other Industry Indicators | Taiwan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Overactive Bladder by Phase | Other Industry Indicators | Taiwan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Urinary Fistula by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Primary Hyperoxaluria Type I by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Unspecified Genito Urinary Disorders by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Nephrotic Syndrome by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Chronic Kidney Disease (Chronic Renal Failure) by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Nocturnal Enuresis by Phase | Other Industry Indicators | Egypt | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Kidney Fibrosis by Phase | Other Industry Indicators | Australia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Acute Renal Failure (ARF) (Acute Kidney Injury) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Focal Segmental Glomerulosclerosis (FSGS) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Secondary Hyperoxaluria by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Urinary Incontinence by Phase | Other Industry Indicators | Switzerland | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Bacterial Cystitis by Phase | Other Industry Indicators | Australia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease) by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Cystitis by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) by Phase | Other Industry Indicators | Canada | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Urethritis by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Membranoproliferative Glomerulonephritis (Mesangiocapillary Glomerulonephritis) by Phase | Other Industry Indicators | Belgium | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Hematuria by Phase | Other Industry Indicators | Malaysia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Urinary Tract Infections by Phase | Other Industry Indicators | Poland | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Renal Failure by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Enuresis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Renal Insufficiency by Phase | Other Industry Indicators | Egypt | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Polyuria (Hyperuresis) by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Glomerulonephritis by Phase | Other Industry Indicators | Netherlands | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Growth Failure In Children With Kidney Disease by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Pollakiuria by Phase | Other Industry Indicators | Iran | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Urinary Retention by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Contrast Induced Nephropathy by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Neurogenic Bladder Dysfunction by Phase | Other Industry Indicators | Czech Republic | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Dysuria by Phase | Other Industry Indicators | Croatia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Inflammation Of Urinary Bladder by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Proteinuria by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Bartter Syndrome by Phase | Other Industry Indicators | Iran | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Renal Osteodystrophy by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Bacteriuria by Phase | Other Industry Indicators | Indonesia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Microalbuminuria by Phase | Other Industry Indicators | Japan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Stress Urinary Incontinence by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Hemorrhagic Cystitis (Haemorrhagic Cystitis) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Hyperoxaluria by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Hypoactive Bladder by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Pyelonephritis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Acute Uncomplicated Cystitis In Women by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Kidney Disease (Nephropathy) by Phase | Other Industry Indicators | Egypt | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Membranous Glomerulonephritis by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Urinary Tract Infections Due To Catheter Encrustation by Phase | Other Industry Indicators | Japan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Nephrocalcinosis by Phase | Other Industry Indicators | France | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Genito Urinary System And Sex Hormones by Phase | Other Industry Indicators | Netherlands | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Pyuria by Phase | Other Industry Indicators | Serbia | Number of clinical trials for drugs | Healthcare | Oct 2021 |
Still looking?
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Explorer
Access more premium companies when you subscribe to Explorer